Zhu et al. study has pointed out that malignant tumors will induce anemia and initiate extramedullary hematopoiesis, which results in abnormal CD45+ endothelial progenitor cells (EPCs) accumulated in the spleen and liver. The gene discussed is PTPRC; the disease is anemia (phenotype).